Regulatory/Legislation

GOP Buoyed by Election Outcome; Democrats View Economic Plan as Difference Maker in 2022

November 8, 2021

By Pete Evich, AAHP Lobbyist and Vice President at Van Scoyoc Associates   Republicans touted their electoral gains across the country on Tuesday, Nov. 2, believing that voters may be rejecting the policies that Democrats are pursuing in Washington. However, as Democrats came to terms with the statewide voting results, the party’s lawmakers in Congress…

FDA’s Growing Expertise in Homeopathic Manufacturing

October 15, 2021

  By George Bernstein, PhD If you have participated in AAHP Summits over the past couple of years, you are no doubt aware that FDA has raised the bar regarding compliance by homeopathic manufacturers with 21 CFR Part 211 (GMPs). I have been present in the audit room during FDA inspections of homeopathic manufacturers in…

An In-Depth Review of AAHP’s 2021 Summit

July 19, 2021

Having listened to the speakers at AAHP’s 2021 Summit: Implementing HPUS Guidelines for FDA Compliance, Part 2, I came away with several thoughts that will be important to manufacturers and marketers in the coming months and years. But first a huge thank you to the presenters and the behind-the-scenes organizers of the event. As an…

Success: Implementing HPUS Guidelines for FDA Compliance, Part 2

July 16, 2021

Co-hosted by AAHP and HPCUS on June 15, the Summit: Implementing HPUS Guidelines for FDA Compliance, Part 2 was an overwhelming success from multiple perspectives. This was the second installment of a compliance program being developed by the Homeopathic Pharmacopoeia Convention of the United States (HPCUS) and presented by AAHP. This program aims to develop…

117th Congress and Biden Administration Underway

February 9, 2021

This content is restricted to AAHP members. If you are a member, please login. If you are not a member, click here.Existing Users Log InUsername or EmailPassword Remember Me  

COVID-19 CARES Act Aids Availability of OTC Products

April 23, 2020

On March 27, President Trump signed into law the Coronavirus Aid Relief and Economic Security (CARES) Act (HR 748). This landmark legislation provides financial relief for workers, small businesses, and healthcare professionals affected by the coronavirus…

Homeopathy Mentioned Twice in FDA 2021 Budget Is Telling of Issues to Come

March 18, 2020

By Mark Land, AAHP President | In February, the White House released the President’s Fiscal Year 2021 Budget. Correspondingly, each agency publishes a detailed budget justification…

In Times of Public Health Crisis, Vulnerable Consumers Look to Us for Sound Advice

March 18, 2020

By Mark Land, AAHP President | I have experienced many infectious disease crises thus far in my lifetime and each one was characterized by fear and uncertainty…

New FDA Documents on Cough/Cold Products and Annual Reporting

November 15, 2021

This content is restricted to AAHP members. If you are a member, please login. If you are not a member, click here.Existing Users Log InUsername or EmailPassword Remember Me  

International Coalition of Homeopathic Associations

May 14, 2021

David Skinner of the Canadian Homeopathic Pharmaceutical Association recently wrote that there is a need for an international coalition of homeopathic associations. He makes this recommendation based the perceived need to monitor and respond to the international implications of actions taken by individual regulators. David speaks of “regulatory creep,” a phenomenon whereby regulatory authorities accelerate…

AAHP monitors and reports on current federal regulations, legislation and government policies that affect the homeopathic community. AAHP is often the first to learn of regulatory changes that have both direct and indirect effects on our industry enabling members to stay ahead of the curve in a rapidly changing healthcare environment.

Leave a Comment

You must be logged in to post a comment.